Board certified in Psychiatric Pharmacy Practice, her primary area of interest and research is in schizophrenia, mood disorders, and adverse effects of psychotropics.
Specialty Area:
Dr. Jackson's research interest is focused on adverse effects, post-marketing surveillance, and new uses of psychiatric medications. Her primary interest is schizophrenia and affective disorders, but she has done research in multiple areas of psychopharmacology.
